Department of Orthodontics and Dentofacial Orthopaedics, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Clin Oral Investig. 2021 Mar;25(3):1547-1558. doi: 10.1007/s00784-020-03462-7. Epub 2020 Aug 13.
The aim of this single-center randomized controlled trial (NCT03753256) was to assess orthodontic surface sealant layer thickness and integrity in vivo during a 12-month follow-up by optical coherence tomography (OCT).
Using a split-mouth design, quadrants of 20 patients treated with fixed orthodontic appliances were included. Quadrants were randomly assigned to the sealants Pro Seal® (PS) or Opal® Seal™ (OS). OCT scans were performed immediately after the application of the sealants and after 3, 6, 9, and 12 months. Sealant layer thicknesses and their integrity were determined at 5 regions of interest (ROIs) known for high risks of demineralization. Sealant integrity loss was determined using a self-developed scale.
A total of 16 patients successfully completed the study. The studied sealants showed significant differences in initial layer thickness. Mean layer thickness was significantly lower for PS (67.8 μm, (95% CI, 56.1-79.5)) than for OS (110.7 μm, (95% CI, 97.3-124.1)). Layer thickness loss was significant after 3 months for PS and after 6 months for OS. Sealant integrity was compromised in more than 50% of the ROIs already after 3 months for both sealants.
Patients treated with fixed orthodontic surface sealants lost the integrity of the protective layer in more than 50% of cases after 3 months, and the layer thickness of the sealants was significantly reduced after 3-6 months.
The protective effect against demineralization lesions of orthodontic sealants in patients treated with fixed appliances appears to be limited in time. Further preventive measures should be investigated.
ClinicalTrials.gov (NCT03753256).
本单中心随机对照试验(NCT03753256)旨在通过光相干断层扫描(OCT)在 12 个月的随访中评估正畸表面密封层厚度和完整性。
采用分口设计,将 20 名接受固定正畸矫治器治疗的患者的象限纳入研究。将象限随机分配到密封剂 Pro Seal®(PS)或 Opal® Seal™(OS)。密封剂应用后即刻以及应用后 3、6、9 和 12 个月进行 OCT 扫描。在已知脱矿风险较高的 5 个感兴趣区域(ROI)确定密封层厚度及其完整性。使用自行开发的量表确定密封完整性损失。
共有 16 名患者成功完成了研究。研究中的密封剂在初始层厚度上存在显著差异。PS 的平均层厚度明显低于 OS(PS 为 67.8μm,95%CI 为 56.1-79.5;OS 为 110.7μm,95%CI 为 97.3-124.1)。PS 在 3 个月后和 OS 在 6 个月后厚度损失显著。两种密封剂在 3 个月后,超过 50%的 ROI 出现密封完整性受损。
接受固定正畸表面密封剂治疗的患者在 3 个月后超过 50%的情况下失去了保护层的完整性,并且密封剂的厚度在 3-6 个月后显著减少。
固定矫治器治疗患者的正畸密封剂对脱矿病变的保护作用似乎在时间上有限。应进一步研究预防措施。
ClinicalTrials.gov(NCT03753256)。